How to manage estrogen during anabolic compound use. This guide covers how aromatisation works, when and how to use aromatase inhibitors, AIs versus SERMs, crashed estrogen recovery, and why balance matters more than suppression.
About a 13-minute readWhy estrogen matters
Estrogen is not the enemy. This is the single most important thing to understand before touching an aromatase inhibitor. In men, estrogen is essential for normal function - and aggressively suppressing it causes more problems than elevated estrogen ever would.
What estrogen does in men
- Libido and sexual function - estrogen is directly required for male sex drive and erectile quality. Crash it and libido goes with it, even on plenty of testosterone.
- Bone mineral density - estrogen is the primary regulator of bone density in men, even more important than testosterone. Low estrogen weakens bone regardless of testosterone levels.
- Joint health - adequate estrogen keeps joints lubricated. Crashed estrogen causes dry, painful, cracking joints - one of the most recognisable symptoms.
- Body composition - estradiol influences fat mass in men as much as testosterone does, and crashing it tends to add fat rather than remove it.
- Cardiovascular protection - estrogen supports healthy cholesterol balance and vascular function. Long-term over-suppression can worsen lipids and vascular health.
- Mood and cognition - estrogen supports emotional stability, memory, and focus. Crashed estrogen brings depression, anxiety, and brain fog.
- Muscle growth - estrogen has anti-inflammatory and anti-catabolic properties during training, and plays a supporting role in muscle growth.
How aromatisation works
Aromatisation is the process by which testosterone (and other aromatisable compounds) are converted into estrogen. This conversion is performed by the aromatase enzyme, which is found primarily in fat tissue, the liver, and the testes.
The conversion process
- You inject testosterone (or another aromatisable compound like Dianabol or Nandrolone).
- The aromatase enzyme converts a portion of that testosterone into estradiol (E2) - the primary form of estrogen in men.
- The more testosterone you have circulating, the more raw material is available for conversion - so estrogen rises proportionally.
- At supraphysiological testosterone doses, estrogen can rise above comfortable levels, causing side effects.
What aromatises and what does not
Aromatises
- Testosterone (all esters) - the primary aromatising compound
- Dianabol (Methandrostenolone) - aromatises heavily
- Nandrolone (Deca, NPP) - aromatises partially, about 20% the rate of testosterone
- Boldenone (EQ) - aromatises mildly
Does not aromatise
- Masteron (Drostanolone) - also has anti-estrogenic properties
- Primobolan (Methenolone)
- Trenbolone - does not aromatise but causes prolactin-related sides
- Anavar (Oxandrolone)
- Winstrol (Stanozolol)
- Turinabol
- All SARMs
Factors that increase aromatisation
- Higher body fat - adipose tissue contains aromatase. The more body fat you carry, the more testosterone converts to estrogen.
- Higher doses - more substrate means more conversion. Estrogen rises disproportionately at higher testosterone doses.
- Stacking aromatisable compounds - testosterone + Dianabol produces significantly more estrogen than testosterone alone.
- Alcohol consumption - alcohol increases aromatase activity.
- Genetics - some people are naturally high aromatisers regardless of body fat or dose.
Signs of high vs low estrogen
Learning to recognise the symptoms of high and low estrogen is important because the treatments are opposite - and misdiagnosing one as the other makes things worse. Many symptoms overlap, which is why bloodwork is the only reliable way to confirm.
High estrogen (elevated E2)
- Water retention - puffy face, swollen ankles, bloated appearance
- Puffy or sensitive nipples - early sign of gynaecomastia development
- High blood pressure - from water retention
- Mood swings - emotional volatility, irritability, crying
- Libido fluctuations - can go high then drop
- Acne - particularly on the back and shoulders
- Bloating - abdominal distension, feeling "soft"
Low estrogen (crashed E2)
- Dry, painful joints - the most distinctive symptom. Knees, elbows, and shoulders ache without explanation.
- Zero libido - complete loss of sex drive and erectile dysfunction
- Depression and anxiety - flat mood, emotional numbness, or panic
- Fatigue - constant tiredness regardless of sleep
- Dry skin and lips - dehydrated appearance
- Insomnia - difficulty falling or staying asleep
- Flat, stringy muscles - loss of fullness and pumps
- Night sweats
- Loss of appetite
Aromatase inhibitors
Aromatase inhibitors (AIs) block the aromatase enzyme, reducing the conversion of testosterone to estrogen. They are tools for managing elevated estrogen during a cycle - not routine additions to every protocol.
You only need an AI if estrogen rises too high. Base decisions on symptoms and bloodwork, not fear or "just in case" logic.
Anastrozole (Arimidex)
Arimimed 1 contains anastrozole - a reversible aromatase inhibitor. It is the most commonly used AI and the easiest to dose and adjust.
| Detail | Anastrozole |
|---|---|
| Type | Reversible inhibitor - binds temporarily to aromatase |
| Half-life | ~48 hours |
| Typical dose | 0.25-0.5 mg every other day |
| Advantages | Easy to dose, flexible, good all-purpose AI |
| Considerations | Reversible binding means estrogen can rebound if stopped suddenly |
Best suited for moderate testosterone doses (300-600 mg/week). Easy to adjust up or down based on bloodwork. The most forgiving AI for beginners because its effects reverse quickly if you overshoot.
Exemestane (Aromasin)
Aromamed 25 contains exemestane - a suicidal (irreversible) aromatase inhibitor. It permanently destroys aromatase enzyme molecules rather than temporarily blocking them.
| Detail | Exemestane |
|---|---|
| Type | Suicidal (irreversible) inhibitor - permanently deactivates aromatase |
| Half-life | ~24 hours |
| Typical dose | 12.5-25 mg every other day (or daily if needed) |
| Advantages | No estrogen rebound when stopped, slightly boosts IGF-1, may protect lipids better |
| Considerations | If you crash estrogen with exemestane, recovery takes longer because new aromatase must be synthesised |
Preferred for users prone to estrogen rebound or bloating on anastrozole. The "suicidal" mechanism means when you stop taking it, estrogen does not spike back up - your body gradually produces new aromatase enzyme instead. This makes it smoother but less forgiving if overdosed.
Letrozole (Femara)
Femamed 2.5 contains letrozole - the most potent aromatase inhibitor available. It is a reversible inhibitor like anastrozole but significantly stronger.
| Detail | Letrozole |
|---|---|
| Type | Strong reversible inhibitor |
| Half-life | ~2 days |
| Typical dose | 0.25-0.5 mg every 2-3 days (low doses only) |
| Best for | Emergency gyno flare-ups, very high-dose testosterone, short-term intervention |
| Considerations | Very easy to crash estrogen. Too strong for routine management in most cases. |
Comparison at a glance
| Factor | Anastrozole | Exemestane | Letrozole |
|---|---|---|---|
| Mechanism | Reversible | Suicidal (irreversible) | Reversible (strong) |
| Potency | Moderate | Moderate | Very strong |
| Estrogen rebound | Possible | No | Possible |
| Crash recovery | Faster (days) | Slower (needs new enzyme) | Faster (days) |
| Lipid impact | Moderate | Milder | Moderate |
| Best use case | Routine management | Rebound-prone users | Emergency / high dose |
| Ease of dosing | Easy | Moderate | Difficult |
SERMs vs AIs - when to use which
SERMs and AIs both deal with estrogen, but they work in fundamentally different ways. Choosing the wrong one for the situation is a common mistake.
How they differ
| Mechanism | Aromatase Inhibitors | SERMs |
|---|---|---|
| What they do | Reduce total estrogen production by blocking aromatase | Block estrogen at specific receptors while leaving levels unchanged |
| Estrogen levels | Lowered systemically | Unchanged - estrogen still circulates but cannot bind at target sites |
| Joint health | Compromised (less estrogen = drier joints) | Preserved (estrogen still available for joints) |
| Libido impact | Can crash libido if overdosed | Minimal impact on libido |
| Gyno protection | Indirect - less estrogen means less binding | Direct - blocks receptors in breast tissue |
When to use an AI
- Estrogen is confirmed elevated on bloodwork (E2 sensitive assay above 60-70 pg/mL)
- You are experiencing clear high-E2 symptoms: significant water retention, high blood pressure, puffy nipples alongside elevated bloodwork
- Running high-dose aromatisable compounds (500+ mg/week testosterone, testosterone + Dianabol)
When to use a SERM instead
- Gyno prevention or treatment - Nolvadex or Raloxifene block estrogen directly at breast tissue receptors without lowering systemic estrogen
- Mild nipple sensitivity - a SERM addresses the symptom at the receptor without crashing estrogen everywhere else
- During PCT - SERMs restart the HPTA while preserving estrogen for recovery. AIs during PCT are almost always a mistake. See our PCT guide.
- When estrogen is normal but you want gyno insurance - a low-dose SERM provides receptor-level protection without touching estrogen levels
Compounds with built-in anti-estrogenic properties
Some anabolic compounds cannot aromatise and additionally exhibit anti-estrogenic activity through direct mechanisms. Incorporating these into a stack can reduce or eliminate the need for a separate AI.
Masteron (Drostanolone)
Available as MASTERMED E 200 (enanthate) and MASTERMED P 100 (propionate). Drostanolone is a DHT-derived compound with three anti-estrogenic pathways:
- Cannot aromatise - as a 5-alpha-reduced compound, it adds zero estrogenic load to the stack
- Inhibits aromatase enzyme - directly suppresses aromatase activity, reducing conversion of other compounds
- Competes at estrogen receptors - blocks estrogen from binding, similar to how SERMs work
This makes Masteron an intelligent choice for users who want estrogen management built into their stack - reducing pill burden and AI side effects while getting anabolic and cosmetic benefits. Its effects are most visible below 12-15% body fat.
Primobolan (Methenolone)
Available as PRIMOMED 100. Methenolone does not aromatise and adds no estrogenic load to a stack. While it lacks the direct anti-estrogenic mechanisms of Masteron, its non-aromatising profile makes it a popular choice for users who want to minimise estrogen management complexity.
Combining testosterone with Primobolan rather than another aromatisable compound means less total aromatisation and potentially no AI needed at moderate testosterone doses.
Practical implications
| Stack | Estrogen management needed |
|---|---|
| Test E 500 mg/week alone | AI likely needed (moderate-high aromatisation) |
| Test E 300 mg + Masteron E 300 mg | AI often unnecessary (Masteron provides built-in control) |
| Test E 300 mg + Primobolan E 400 mg | AI rarely needed (low aromatisable dose, non-aromatising support) |
| Test E 500 mg + Dianabol 40 mg/day | AI almost certainly needed (heavy aromatisation from both) |
Dosing strategies
There is no fixed AI dose that works for everyone. The right dose depends on your total aromatisable compound load, individual aromatase sensitivity, body fat percentage, and baseline estrogen levels. The approach is always: start low, test, adjust.
Starting points by testosterone dose
| Testosterone dose | Suggested AI starting point | Notes |
|---|---|---|
| 200-300 mg/week (TRT+) | Often none needed | Monitor symptoms, get bloodwork at 4-6 weeks |
| 300-500 mg/week | Anastrozole 0.25 mg on injection days | Adjust based on bloodwork at 4-6 weeks |
| 500-700 mg/week | Anastrozole 0.5 mg EOD or Exemestane 12.5 mg EOD | Higher doses = more aromatisation. Bloodwork essential. |
| 700+ mg/week or Test + Dbol | Exemestane 12.5 mg EOD or daily | Heavy aromatisation. Consider switching to daily dosing if symptoms persist. |
These are starting points only. Adjust every 2-3 weeks based on symptoms and bloodwork. The target is not "lowest possible estrogen" - it is estrogen in a comfortable range where you have no symptoms of either high or low E2.
Dosing principles
- Start low - it is easier to increase an AI dose than to recover from crashed estrogen
- Time AI doses with injections - taking your AI on injection days creates a simple, consistent schedule
- Do not pre-load AIs - wait until the cycle is established (2-3 weeks in) before introducing an AI, unless you know from prior cycles that you aromatise heavily
- Adjust based on bloodwork, not anxiety - "I might get gyno" is not a reason to take more AI. Bloodwork showing E2 above 60-70 pg/mL alongside symptoms is a reason.
- Recheck after changes - after any AI dose adjustment, wait 3-4 weeks and retest
Emergency gyno protocol
If you notice a gyno flare-up (painful lump forming under the nipple, not just sensitivity):
- Start Nolvadex 20 mg/day immediately - blocks estrogen at the receptor in breast tissue
- Optionally add Letrozole 1.25 mg/day for 7-10 days - aggressively reduces estrogen production to halt progression
- Taper letrozole after 7-10 days - reduce to 0.5 mg EOD, then transition to moderate anastrozole or exemestane
- Continue Nolvadex for 2-4 weeks after the flare-up resolves
This is the only scenario where letrozole at higher doses is appropriate. It is a short-term emergency intervention, not a routine protocol.
Crashed estrogen
Crashed estrogen (excessively low E2) is one of the worst experiences during a cycle - and it is almost always self-inflicted through AI overuse. You will recognise it from the low-estrogen signs above - dry, aching joints, zero libido, flat mood, fatigue, dry skin. What matters most here is how to recover, because prevention beats treatment every time.
How to recover
- Stop the AI immediately. Do not taper - just stop.
- Wait. If you were using anastrozole (reversible), estrogen typically begins recovering within 2-5 days as the AI clears and aromatase resumes normal function.
- If you were using exemestane (suicidal), recovery takes longer - typically 1-2 weeks - because your body must synthesise new aromatase enzyme to replace what was destroyed.
- When you resume AI use (if needed), restart at a lower dose than what caused the crash.
Bloodwork targets
Bloodwork is the only reliable way to know where your estrogen actually is. Symptoms are useful as early warning signals, but they overlap between high and low E2 - only a blood test gives you the answer.
What to test
| Marker | Why it matters |
|---|---|
| Estradiol (E2) - sensitive assay | The primary estrogen marker. Must be the sensitive (LC-MS/MS) assay, not the standard immunoassay which is inaccurate for men. |
| Total Testosterone | Context for your E2 reading - the ratio matters more than E2 alone |
| SHBG | Affects free hormone levels and how estrogen is metabolised |
| Lipid panel (HDL, LDL) | AIs negatively affect cholesterol. Monitor lipids if using an AI long-term. |
| Blood pressure | Elevated estrogen causes water retention which raises BP |
Target ranges
There is no single "ideal" E2 number - the right level depends on your testosterone level and how you feel. However, general guidelines:
| Context | E2 sensitive assay range | Notes |
|---|---|---|
| Natural / TRT | 20-35 pg/mL | Normal physiological range |
| On cycle (300-500 mg/week) | 30-60 pg/mL | Elevated but proportional to higher testosterone. Most men feel fine here. |
| Symptoms likely | 60-70+ pg/mL | Not everyone gets symptoms here. Some feel fine at 80+. Treat symptoms + bloodwork, not numbers alone. |
| Crashed | Below 10-15 pg/mL | Joint pain, zero libido, depression. Stop AI immediately. |
When to test
- Pre-cycle baseline - establish your natural E2 before starting anything
- 4-6 weeks into the cycle - levels have stabilised, this is when you make AI adjustments
- 3-4 weeks after any AI dose change - confirm the adjustment worked
- If symptoms appear - do not guess. Test.
For a complete guide to bloodwork panels, timing, and how to read results, see our bloodwork guide.
Frequently asked questions
Do I need an AI on every cycle?
No. You only need an AI if estrogen climbs too high. Many moderate-dose cycles with non-aromatising support compounds (Masteron, Primobolan) do not require an AI at all. Bloodwork tells you when - not the compound name or dose alone.
Which AI is best?
Exemestane (Aromasin) is the most forgiving for most users - no estrogen rebound, milder lipid impact. Anastrozole (Arimidex) is the most flexible and easiest to adjust. Letrozole is too strong for routine use - reserve it for emergency gynaecomastia intervention.
Can AIs prevent gyno from Deca or Tren?
No. Gynaecomastia from Nandrolone (Deca) and Trenbolone is caused by prolactin and progesterone, not estrogen. AIs do not affect prolactin. If you are running 19-nor compounds, prolactin management (Cabergoline) is the appropriate tool - not an AI.
Can I run an AI during PCT?
Almost never. During PCT, you need estrogen for recovery - libido, joints, mood, bone density, and cardiovascular health. SERMs already block estrogen at the hypothalamus to stimulate LH/FSH. Adding an AI strips estrogen systemically and makes recovery worse. Only use an AI during PCT if bloodwork confirms estrogen is excessively elevated. See our PCT guide for details.
How long does an AI take to work?
Usually 48-72 hours to notice a difference, depending on the compound and dose. Full stabilisation at the new estrogen level takes about 2 weeks. Do not increase the dose after just a few days - give it time to take full effect.
Can I use a SERM and AI together?
Not for the same problem. If estrogen is high, use an AI. If the concern is specifically gyno, use a SERM. The exception is the emergency gyno protocol where Nolvadex + Letrozole are used together short-term to halt active gyno progression. Do not routinely combine them.
What about natural aromatase inhibitors?
Supplements marketed as "natural AIs" (DIM, calcium D-glucarate, grape seed extract, zinc) have minimal to no clinically meaningful effect on estrogen during a steroid cycle. They may support general estrogen metabolism at physiological levels, but they cannot compete with the aromatisation from supraphysiological testosterone doses. Use pharmaceutical AIs when needed, not supplements.
Does body fat affect how much AI I need?
Yes, significantly. Adipose tissue contains aromatase. The more body fat you carry, the more testosterone converts to estrogen - meaning you may need more AI at the same testosterone dose compared to a leaner individual. Reducing body fat before a cycle is one of the most effective ways to minimise estrogen management complexity.
Can women use AIs?
In medical settings for breast cancer treatment, yes. In performance-enhancement contexts, no - AIs can dangerously crash estrogen in women, causing severe bone loss, cardiovascular risk, and metabolic disruption. Women using anabolic compounds should consult a healthcare provider for hormone management.